Navigation For Mobile

Category Archives: Febuxostat

Analytical Capabilities and Drug Quality – Key to Successful Pharma Outsourcing

Last week, we wrote a post on new analytical methods for the detection of impurities that our R&D group had developed for the drug Febuxostat. And we’ve done the same…

Posted in analytical science, APIs, Capabilities, Chemistry, Contract Manufacturing, CRO/CMO, Febuxostat, genotoxic impurities, method development, Neuland Labs, QA/QC, regulatory | Comments Off on Analytical Capabilities and Drug Quality – Key to Successful Pharma Outsourcing

Investigation of Various Impurities in Febuxostat

In this month’s issue of PharmTech, team members at Neuland’s R&D Center in Hyderabad published a peer-reviewed article on the analysis and management of impurities in the drug Febuxostat. Febuxostat, a…

Posted in analytical science, Capabilities, Chemistry, drugs, Febuxostat, method development, Neuland Labs, peer-review, Pharm Tech, Pharmaceutical Technology, QA/QC, regulatory | Comments Off on Investigation of Various Impurities in Febuxostat